These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 17848497)
1. Design of the fish oil inhibition of stenosis in hemodialysis grafts (FISH) study. Lok CE; Allon M; Donnelly S; Dorval M; Hemmelgarn B; Moist L; Oliver MJ; Tonelli M; Stanley K Clin Trials; 2007; 4(4):357-67. PubMed ID: 17848497 [TBL] [Abstract][Full Text] [Related]
2. Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial. Lok CE; Moist L; Hemmelgarn BR; Tonelli M; Vazquez MA; Dorval M; Oliver M; Donnelly S; Allon M; Stanley K; JAMA; 2012 May; 307(17):1809-16. PubMed ID: 22550196 [TBL] [Abstract][Full Text] [Related]
3. Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical Trial. Irish AB; Viecelli AK; Hawley CM; Hooi LS; Pascoe EM; Paul-Brent PA; Badve SV; Mori TA; Cass A; Kerr PG; Voss D; Ong LM; Polkinghorne KR; JAMA Intern Med; 2017 Feb; 177(2):184-193. PubMed ID: 28055065 [TBL] [Abstract][Full Text] [Related]
4. Clinical protocol. A phase IIb, randomized, multicenter, double-blind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients. Fuster V; Charlton P; Boyd A Hum Gene Ther; 2001 Nov; 12(16):2025-7. PubMed ID: 11727735 [TBL] [Abstract][Full Text] [Related]
7. Fish oil treatment for kidney transplant recipients: a meta-analysis of randomized controlled trials. Lim AK; Manley KJ; Roberts MA; Fraenkel MB Transplantation; 2007 Apr; 83(7):831-8. PubMed ID: 17460552 [TBL] [Abstract][Full Text] [Related]
8. Fish oil and hemodialysis graft patency: does time matter? Dixon BS JAMA; 2012 May; 307(17):1859-60. PubMed ID: 22550201 [No Abstract] [Full Text] [Related]
9. Some old drugs improve late primary patency rate of native arteriovenous fistulas in hemodialysis patients. Righetti M; Ferrario G; Serbelloni P; Milani S; Tommasi A Ann Vasc Surg; 2009; 23(4):491-7. PubMed ID: 18973987 [TBL] [Abstract][Full Text] [Related]
10. Patency rate and complications of vascular access grafts for hemodialysis in lower extremities. Salimi J Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):929-32. PubMed ID: 18974578 [TBL] [Abstract][Full Text] [Related]
11. Effects of omega-3 fatty acid supplementation on vascular access thrombosis in polytetrafluorethylene grafts. Bowden RG; Wilson RL; Gentile M; Ounpraseuth S; Moore P; Leutholtz BC J Ren Nutr; 2007 Mar; 17(2):126-31. PubMed ID: 17321952 [TBL] [Abstract][Full Text] [Related]
12. Vascular access outcomes in the elderly hemodialysis population: A USRDS study. Chan MR; Sanchez RJ; Young HN; Yevzlin AS Semin Dial; 2007; 20(6):606-10. PubMed ID: 17991212 [TBL] [Abstract][Full Text] [Related]
13. [How to predict thrombosis of arteriovenous fistule?]. Kapun S; Zibar L Acta Med Croatica; 2008 Feb; 62(1):9-13. PubMed ID: 18365494 [TBL] [Abstract][Full Text] [Related]
14. Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial. Dember LM; Kaufman JS; Beck GJ; Dixon BS; Gassman JJ; Greene T; Himmelfarb J; Hunsicker LG; Kusek JW; Lawson JH; Middleton JP; Radeva M; Schwab SJ; Whiting JF; Feldman HI; Clin Trials; 2005; 2(5):413-22. PubMed ID: 16317810 [TBL] [Abstract][Full Text] [Related]
15. Disparity in outcomes of surgical revascularization for limb salvage. Race and gender are synergistic determinants of vein graft failure and limb loss. Nguyen LL, Hevelone N, Rogers SO, Bandyk DF, Clowes AW, Moneta GL, Lipsitz S, Conte MS. Circulation. 2009; 119: 123-130. Kreatsoulas C; Anand SS Vasc Med; 2009 Nov; 14(4):397-9. PubMed ID: 19808727 [TBL] [Abstract][Full Text] [Related]
16. Secondary patency of thrombosed prosthetic vascular access grafts with aggressive surveillance, monitoring and endovascular management. Kakkos SK; Haddad GK; Haddad JA; Scully MM Eur J Vasc Endovasc Surg; 2008 Sep; 36(3):356-65. PubMed ID: 18603454 [TBL] [Abstract][Full Text] [Related]
17. The pathogenesis of hemodialysis vascular access failure and systemic therapies for its prevention: Optimism unfulfilled. Viecelli AK; Mori TA; Roy-Chaudhury P; Polkinghorne KR; Hawley CM; Johnson DW; Pascoe EM; Irish AB Semin Dial; 2018 May; 31(3):244-257. PubMed ID: 29178510 [TBL] [Abstract][Full Text] [Related]
18. Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study. Saran R; Elder SJ; Goodkin DA; Akiba T; Ethier J; Rayner HC; Saito A; Young EW; Gillespie BW; Merion RM; Pisoni RL Ann Surg; 2008 May; 247(5):885-91. PubMed ID: 18438128 [TBL] [Abstract][Full Text] [Related]
19. Conversion of vascular access type among incident hemodialysis patients: description and association with mortality. Bradbury BD; Chen F; Furniss A; Pisoni RL; Keen M; Mapes D; Krishnan M Am J Kidney Dis; 2009 May; 53(5):804-14. PubMed ID: 19268411 [TBL] [Abstract][Full Text] [Related]
20. The patency rate and complications of polytetrafluoroethylene vascular access grafts in hemodialysis patients: a prospective study from Iran. Salimi J; Zafarghandi MR Saudi J Kidney Dis Transpl; 2008 Mar; 19(2):280-5. PubMed ID: 18310884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]